Condition
Healthy Volunteers
Diabetes Mellitus, Type 2
Locations
Austria
Start date
04/05/2026
Identifiers
Trial ID NN1679-8505,
NCT number NCT07570992,
Eudract number Not Available
NCT number NCT07570992,
Eudract number Not Available
Summary
This study is testing a new medicine that might help treat people with type 2 diabetes. The purpose of the study is to see if the new study medicine is safe and how well is tolerated by the body. There will be two groups of participants in this study: healthy participants and participants with type 2 diabetes. Participant will either get study medicine (NNC1679-0001) or placebo (a treatment that has no active medicine in it). NNC1679-0001 is a new experimental medicine that doctors cannot prescribe yet. Which treatment the participant gets is decided by chance. Participant will get one dose which will be injected into the area around abdomen (belly) by the medical staff.
Trial Overview:
Treatment
DRUG: NNC1679-0001
DRUG: Placebo
Study type
INTERVENTIONAL
Trial duration
May 04 2026 - Jun 25 2028
Participants
58
Phase
I
Are you eligible?
Gender
Male and female
Age
18 to 64 years old
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.